Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Patient Blood Management: Market Share, and Growth Analysis by Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), Application, End User, Technology" has been added to ResearchAndMarkets.com's offering.
The Patient Blood Management (PBM) market, valued at USD 13.9 billion in 2025, is projected to reach USD 23 billion by 2033, experiencing a CAGR of 6.51%
The market is propelled by increasing surgical procedures, a rise in blood-related disorders, and advancements in transfusion technology. PBM optimizes blood use, minimizes transfusions, and enhances healthcare efficiency, addressing risks such as infections and immune reactions.
Major players like Haemonetics, Fresenius Kabi, Terumo, and Becton Dickinson are investing in advanced technologies, including blood conservation and automated processing systems. The growing emphasis on personalized medicine and regulatory guidelines promoting blood conservation are further driving PBM adoption. As healthcare systems shift towards cost-effective patient-centered care, PBM solutions are becoming essential in modern clinical practice.
Technological advancements in 2024 have significantly impacted the PBM market, with innovations in blood-saving techniques and real-time monitoring systems. AI-driven blood utilization analytics improve clinical decision-making, reducing unnecessary transfusions. Autologous blood transfusion methods are gaining traction, reducing dependency on donor blood. Minimally invasive and bloodless surgical techniques are decreasing transfusion rates and enhancing recovery. Point-of-care testing solutions for real-time hemoglobin and coagulation monitoring support personalized transfusion strategies. Despite these advancements, challenges such as limited PBM awareness in developing regions and high technology costs persist.
Looking to 2025 and beyond, AI, machine learning, and automation will further integrate into PBM, enhancing transfusion decision-making. Predictive analytics will optimize blood inventory management, reducing waste and ensuring availability. The development of synthetic blood substitutes is anticipated, providing alternatives to shortages and dependency. Blockchain technology will improve blood supply chain transparency and safety. Expanding PBM education programs will drive wider adoption of conservation techniques, especially in emerging markets. As value-based care models gain momentum, PBM will be integral in clinical workflows, improving patient safety, reducing costs, and enhancing treatment outcomes.
Key Insights: Patient Blood Management Market
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value (USD) in 2025 | $13.9 Billion |
| Forecasted Market Value (USD) by 2033 | $23 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Market Segmentation
Patient Blood Management Market Data and Trends
Competitive Intelligence and Key Players
For more information about this report visit https://www.researchandmarkets.com/r/11dmfe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment